The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [BIOQUELL PLC] - Replacement

8 Jan 2019 10:19

RNS Number : 5081M
ODDO BHF Asset Management SAS
08 January 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

ODDO BHF Asset Management SAS

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BIOQUELL PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

07/01/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

72 673

0.33%

(2) Cash-settled derivatives:

 

399 000

1.78%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

471 673

2.11%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary

Purchase

72 673

580 GBp

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

Increasing a long position

229 000

580 GBp

 

 (c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

08/01/2019

Contact name:

Lou PINHEIRO

 

+33 1 44 51 81 38

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETCKFDKKBKDCDK
Date   Source Headline
16th Jan 201910:46 amRNSForm 8.5 (EPT/RI) Bioquell Plc
16th Jan 201910:10 amRNSScheme of Arrangement becomes Effective
15th Jan 201912:00 pmRNSForm 8.5 (EPT/RI) Bioquell Plc
14th Jan 201912:20 pmRNSCourt Approval of Scheme
14th Jan 20199:23 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
11th Jan 20199:34 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
10th Jan 20195:30 pmRNSBioquell
10th Jan 20191:10 pmRNSResults of Court Meeting and General Meeting
10th Jan 20199:42 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
9th Jan 201911:51 amRNSForm 8.5 (EPT/RI) - Bioquell Plc
8th Jan 20192:15 pmRNSForm 8.3 - Bioquell plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI) Bioquell Plc
8th Jan 201910:19 amRNSForm 8.3 - [BIOQUELL PLC] - Replacement
8th Jan 20199:50 amRNSForm 8.3 - BIOQUELL PLC
7th Jan 201911:37 amRNSForm 8.5 (EPT/RI) Bioquell plc
3rd Jan 20199:54 amRNSForm 8.5 (EPT/RI) Bioquell Plc
2nd Jan 20199:26 amRNSForm 8.5 (EPT/RI) Bioquell Plc
27th Dec 201810:50 amRNSForm 8.5 (EPT/RI) Bioquell Plc
24th Dec 201810:16 amRNSForm 8.5 (EPT/RI) Bioquell Plc
21st Dec 201810:21 amRNSForm 8.5 (EPT/RI) Bioquell Plc
20th Dec 201810:29 amRNSForm 8.5 (EPT/RI) Bioquell Plc
19th Dec 201810:26 amRNSForm 8.5 (EPT/RI) Bioquell Plc
18th Dec 201811:36 amRNSPublication of Scheme Document
18th Dec 201811:15 amRNSForm 8.5 (EPT/RI) Bioquell Plc
17th Dec 201812:22 pmRNSDisclosure under Rule 2.10
17th Dec 201810:28 amRNSForm 8.5 (EPT/RI) - Bioquell PLC
14th Dec 201811:30 amRNSForm 8.5 (EPT/RI) Bioquell Plc
13th Dec 20183:13 pmRNSForm 8.3 - Bioquell plc
13th Dec 20189:27 amRNSForm 8.5 (EPT/RI) Bioquell Plc
12th Dec 201810:53 amRNSForm 8.5 (EPT/RI) Bioquell Plc
11th Dec 201810:26 amRNSForm 8.5 (EPT/RI) Bioquell Plc
10th Dec 20186:02 pmRNSPDMR dealing and Rule 2.10 announcement
10th Dec 20183:33 pmRNSForm 8.3 - Bioquell plc
10th Dec 201810:31 amRNSForm 8.5 (EPT/RI) Bioquell Plc
10th Dec 20189:14 amRNSForm 8 (OPD) - Bioquell PLC - Replacement
7th Dec 20183:06 pmRNSForm 8.5 (EPT/RI) - Bioquell PLC
6th Dec 20185:17 pmRNSForm 8.3 - Bioquell PLC
6th Dec 201810:45 amRNSForm 8.5 (EPT/RI) Bioquell Plc
5th Dec 201811:44 amRNSForm 8.3 - BIOQUELL PLC
5th Dec 20189:58 amRNSForm 8.5 (EPT/RI) Bioquell Plc
4th Dec 20185:13 pmRNSForm 8.3 - Bioquell PLC
4th Dec 201812:17 pmRNSForm 8.5 (EPT/RI) Bioquell Plc
4th Dec 201811:16 amRNSForm 8.3 - Bioquell Plc
4th Dec 201810:34 amRNSForm 8 (OPD) Bioquell PLC
3rd Dec 201811:22 amRNSForm 8.5 (EPT/RI) Bioquell Plc
3rd Dec 201810:53 amRNSForm 8.3 - Bioquell plc
3rd Dec 201810:44 amGNWForm 8.3 - [Bioquell plc]
30th Nov 20183:00 pmRNSForm 8.3 - Bioquell PLC
30th Nov 20181:31 pmRNSForm 8.3 - Bioquell Plc
30th Nov 201812:05 pmRNSForm 8.3 - Bioquell Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.